European Journal of Clinical Oncology

ISSN - 2732-2654

Luca Malorni

Dr, Department of Medical Oncology, Hospital of Prato, Prato, Italy


  • Commentary   
    A Brief Synoptic Note on Chemotherapy for Cancer Patients
    Author(s): Luca Malorni*

    Chemotherapy has come back to imply non-specific usage of intracellular poisons to inhibit cell division or induce Deoxyribonucleic Acid (DNA) harms, specifically inhibition of deoxyribonucleic acid repair will augment therapy. The implication of the word therapy excludes additional selective agents that block extracellular signals (signal transduction). The result of therapies with specific molecular or genetic targets, that inhibit growth-promoting signals from classic endocrine hormones primarily estrogens for carcinoma and androgens for prostate cancer area unit currently known as secretion therapies. Different inhibitions of growth-signals like those related to receptor Aminopolycarboxylic Acid (APCA) kinases area unit are targeted medical therapy... View More»

    Abstract HTML PDF